Page 53 - Read Online

ALHulais et al. J Cancer Metastasis Treat 2019;5:3 I http://dx.doi.org/10.20517/2394-4722.2018.71 Page 23 of 23

210. Huang C, Chen Y, Liu H, Yang J, Song X, et al. Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2
and down-regulating the Wnt pathway activity. Oncotarget 2017;8:115254-69.
211. Jin CH, Wang AH, Chen JM, Li RX, Liu XM, et al. Observation of curative efficacy and prognosis following combination chemotherapy
with celecoxib in the treatment of advanced colorectal cancer. J Int Med Res 2011;39:2129-40.
212. Debucquoy A, Roels S, Goethals L, Libbrecht L, Van Cutsem E, et al. Double blind randomized phase II study with radiation+5-
fluorouracil+/-celecoxib for resectable rectal cancer. Radiother Oncol 2009;93:273-8.
213. Lin E, Morris JS, Ayers GD. Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. Oncology (Williston
Park) 2002;16:31-7.
214. Lin EH, Curley SA, Crane CC, Feig B, Skibber J, et al. Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer:
potential benefits and COX-2 as the common mediator in pain, toxicities and survival? Am J Clin Oncol 2006;29:232-9.
215. Arber N, Eagle CJ, Spicak J, Racz I, Dite P, et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med
2006;355:885-95.
216. Arber N, Spicak J, Racz I, Zavoral M, Breazna A, et al. Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial.
Am J Gastroenterol 2011;106:1135-46.
217. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, et al. Five-year efficacy and safety analysis of the Adenoma Prevention with
Celecoxib Trial. Cancer Prev Res (Phila) 2009;2:310-21.
218. Mason RP, Walter MF, Day CA, Jacob RF. A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other
COX-2 selective agents and NSAids. Subcell Biochem 2007;42:175-90.
219. Nissen SE, Yeomans ND, Solomon DH, Luscher TF, Libby P, et al. Cardiovascular safety of Celecoxib, Naproxen, or Ibuprofen for arthritis.
N Engl J Med 2016;375:2519-29.